Curacle Co (365270.KQ) Stock Price

Curacle Co Price

CLOSED
9,770.00
​
Market closed

Revenue at Curacle Co has contracted by 81.6% per year over the past 4 years to 7.10 M KRW. For Curacle Co, the net margin of -255,057.9% is down versus -106.8% a few years ago.

Curacle Co stock price

Access this data via the Eulerpool API

Curacle Co business model & stock analysis

Curacle Co., Ltd. is engaged in the business of research and experimental development on medical sciences and pharmacy. The company is headquartered in Seoul, Seoul and currently employs 35 full-time employees. The company went IPO on 2021-07-22. The firm researches and develops synthetic drugs CU06-RE, CU01, and natural drug CU03 as new drugs for intractable vascular diseases. The Company’s drugs are used for diabetic macular edema (DME), diabetic nephropathy (DN), and wet age-related macular degeneration (wet AMD). In addition, the Company uses the SOLVADYS platform technology, a platform technology for the development of vascular endothelial dysfunction blockers.

Frequently asked questions about Curacle Co

Converted at the current exchange rate, the Curacle Co share trades at 6.50 EUR (9,770.00 KRW).

The revenue cannot currently be calculated for Curacle Co.

The profit cannot currently be calculated for Curacle Co.

The P/E ratio cannot be calculated for Curacle Co at the moment.

The P/S cannot be calculated for Curacle Co currently.

The Eulerpool Quality Score for Curacle Co is 2/10.

The ISIN of Curacle Co is KR7365270008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Curacle Co is 365270.KQ. The ticker symbol is used to trade Curacle Co shares on the stock exchange.

Fair ValueTerminal
10,356.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
202,898.86 KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website curacle.com
Country
South Korea
Currency
KRW
Initial public offering
Jul 22, 2021
ISIN
KR7365270008
Cusip
Y1R37G152
Market capitalization
154.52 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-45.18 %
Last updated Oct 9, 2026, 12:28 PM

Curacle Co Peer Group

Curacle Co FIGI

365270:KS · BBG011F820J9365270:KQ · BBG011F820L6

All fundamentals and in-depth analysis of Curacle Co

Our stock analysis for Curacle Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Curacle Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.